Air Insulated Switchgear Market Players:
- C and S Electric Ltd.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CG Power and Industrial Solutions Ltd.
- Eaton Corp. Plc
- ELATEC POWER DISTRIBUTION GmbH
- EPE Switchgear M Sdn. Bhd.
- General Electric Co.
- Larsen and Toubro Ltd.
- Lucy Group Ltd.
- Schneider Electric SE
- Siemens AG
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of air insulated switchgear is assessed at USD 74.68 billion.
The global air insulated switchgear market size was valued at over USD 70.79 billion in 2025 and is expected to expand at a CAGR of around 6.1%, surpassing USD 127.98 billion revenue by 2035.
The Asia Pacific air insulated switchgear market will hold over 38% share by 2035, attributed to the rising focus on conserving and ensuring nonstop power supply.
Key players in the market include Bayer AG, Mayne Pharma Group Limited, PULMATRiX Inc., Endo International Plc, Johnson & Johnson Services Inc., GlaxoSmithKline Plc, Pfizer Inc., Abbott, Takeda Pharmaceutical Company Limited, Novartis AG, Shionogi & Co., Ltd., Asahi Kasei Pharma Corporation, F2G Ltd., Regeneron Pharmaceutical Inc.
